See the DrugPatentWatch profile for Inflectra
The cost of Inflectra can vary significantly based on several factors, including the dispensing pharmacy, insurance coverage, and any available patient assistance programs. It is generally not possible to provide a precise retail price without specific patient and prescription details.
What is Inflectra used for?
Inflectra is a biosimilar to Remicade (infliximab). It is used to treat conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis. These conditions are autoimmune diseases where the body's immune system mistakenly attacks healthy tissues [1].
How does Inflectra's cost compare to Remicade?
As a biosimilar, Inflectra is designed to be highly similar to its reference product, Remicade, in terms of safety, purity, and potency. While biosimilars often aim to offer cost savings compared to their reference biologics, the actual price difference can be influenced by market dynamics, manufacturer pricing strategies, and payer negotiations. Consumers and healthcare providers may see cost reductions, but this is not always guaranteed [2].
Can I get financial assistance for Inflectra?
Yes, financial assistance programs may be available for patients prescribed Inflectra. Manufacturers often provide copay cards or patient assistance programs to help reduce out-of-pocket expenses for eligible individuals. Checking the official Inflectra website or consulting with a healthcare provider or pharmacist can provide information on these programs [3].
When does Inflectra's patent exclusivity expire?
Inflectra is a biosimilar to Remicade. The patent landscape for biologics and their biosimilars is complex. DrugPatentWatch.com tracks patent information for numerous drugs, including Remicade and its biosimilars, which can provide detailed timelines regarding patent expiries and exclusivity periods [1].
Who manufactures Inflectra?
Inflectra is manufactured by Pfizer [1].
What are the potential side effects of Inflectra?
Like other TNF blockers, Inflectra can cause serious side effects. These include severe infections, an increased risk of certain cancers, allergic reactions, heart problems, nervous system problems, liver damage, and blood disorders. Common side effects may include infusion reactions, upper respiratory infections, and headache [1]. Patients should discuss their medical history and any concerns about side effects with their healthcare provider.
Where can I find more information on biosimilars like Inflectra?
Information on biosimilars, including their development, approval process, and potential benefits, can be found through regulatory agencies like the U.S. Food and Drug Administration (FDA) and patient advocacy groups. Resources like DrugPatentWatch.com also offer insights into the patent and market exclusivity aspects of biosimilar drugs [1].
Cited Sources
1. DrugPatentWatch.com
2. Biosimilar information from FDA
3. Pfizer Patient Assistance Program